- call +1-201-465-4211
- email sales@mrinsights.biz
Imatinib is a chemotherapy drug that acts by reducing or preventing the progression of cancer cells. This drug is used for the treatment of certain cancers such as chronic myeloid leukemia, acute lymphoblastic leukemia, gastrointestinal tumors, certain skin tumors (dermatofibrosarcoma protuberans), and myelodysplastic/myeloproliferative diseases.
Scope of the Report:
This report focuses on the Imatinib Drug in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Growth in prevalence of cancer, increase in demand for target drug therapy, and patent expiry of imatinib drug are expected to drive the imatinib drug market. Furthermore, rise in healthcare expenditure and increase in awareness of cancer by government and private organizations are anticipated to boost the market growth.
The worldwide market for Imatinib Drug is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Novartis
Glenmark Pharmaceuticals Ltd.
Sun Pharmaceuticals
Actavis Generics
Dr. Reddy's Laboratories
Teva Pharmaceutical Industries Ltd.
Sanofi S.A.
Cipla Inc.
Apotex Inc.
Mylan Pharms Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Tablets
Capsules
Market Segment by Applications, can be divided into
Chronic myelogenous leukemia
Gastrointestinal stromal tumors
Others
There are 15 Chapters to deeply display the global Imatinib Drug market.
Chapter 1, to describe Imatinib Drug Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Imatinib Drug, with sales, revenue, and price of Imatinib Drug, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Imatinib Drug, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Imatinib Drug market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Imatinib Drug sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Imatinib Drug Introduction
1.2 Market Analysis by Type
1.2.1 Tablets
1.2.2 Capsules
1.3 Market Analysis by Applications
1.3.1 Chronic myelogenous leukemia
1.3.2 Gastrointestinal stromal tumors
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Business Overview
2.1.2 Imatinib Drug Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Novartis Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Glenmark Pharmaceuticals Ltd.
2.2.1 Business Overview
2.2.2 Imatinib Drug Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Glenmark Pharmaceuticals Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Sun Pharmaceuticals
2.3.1 Business Overview
2.3.2 Imatinib Drug Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Sun Pharmaceuticals Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Actavis Generics
2.4.1 Business Overview
2.4.2 Imatinib Drug Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Actavis Generics Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Dr. Reddy's Laboratories
2.5.1 Business Overview
2.5.2 Imatinib Drug Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Dr. Reddy's Laboratories Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Teva Pharmaceutical Industries Ltd.
2.6.1 Business Overview
2.6.2 Imatinib Drug Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Teva Pharmaceutical Industries Ltd. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Sanofi S.A.
2.7.1 Business Overview
2.7.2 Imatinib Drug Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Sanofi S.A. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Cipla Inc.
2.8.1 Business Overview
2.8.2 Imatinib Drug Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Cipla Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Apotex Inc.
2.9.1 Business Overview
2.9.2 Imatinib Drug Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Apotex Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Mylan Pharms Inc.
2.10.1 Business Overview
2.10.2 Imatinib Drug Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Mylan Pharms Inc. Imatinib Drug Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Imatinib Drug Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Imatinib Drug Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Imatinib Drug Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Imatinib Drug Manufacturer Market Share in 2017
3.3.2 Top 6 Imatinib Drug Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Imatinib Drug Market Analysis by Regions
4.1 Global Imatinib Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Imatinib Drug Sales and Market Share by Regions (2013-2018)
4.1.2 Global Imatinib Drug Revenue and Market Share by Regions (2013-2018)
4.2 North America Imatinib Drug Sales and Growth Rate (2013-2018)
4.3 Europe Imatinib Drug Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Imatinib Drug Sales and Growth Rate (2013-2018)
4.5 South America Imatinib Drug Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Imatinib Drug Sales and Growth Rate (2013-2018)
5 North America Imatinib Drug by Countries
5.1 North America Imatinib Drug Sales, Revenue and Market Share by Countries
5.1.1 North America Imatinib Drug Sales and Market Share by Countries (2013-2018)
5.1.2 North America Imatinib Drug Revenue and Market Share by Countries (2013-2018)
5.2 United States Imatinib Drug Sales and Growth Rate (2013-2018)
5.3 Canada Imatinib Drug Sales and Growth Rate (2013-2018)
5.4 Mexico Imatinib Drug Sales and Growth Rate (2013-2018)
6 Europe Imatinib Drug by Countries
6.1 Europe Imatinib Drug Sales, Revenue and Market Share by Countries
6.1.1 Europe Imatinib Drug Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Imatinib Drug Revenue and Market Share by Countries (2013-2018)
6.2 Germany Imatinib Drug Sales and Growth Rate (2013-2018)
6.3 UK Imatinib Drug Sales and Growth Rate (2013-2018)
6.4 France Imatinib Drug Sales and Growth Rate (2013-2018)
6.5 Russia Imatinib Drug Sales and Growth Rate (2013-2018)
6.6 Italy Imatinib Drug Sales and Growth Rate (2013-2018)
7 Asia-Pacific Imatinib Drug by Countries
7.1 Asia-Pacific Imatinib Drug Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Imatinib Drug Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Imatinib Drug Revenue and Market Share by Countries (2013-2018)
7.2 China Imatinib Drug Sales and Growth Rate (2013-2018)
7.3 Japan Imatinib Drug Sales and Growth Rate (2013-2018)
7.4 Korea Imatinib Drug Sales and Growth Rate (2013-2018)
7.5 India Imatinib Drug Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Imatinib Drug Sales and Growth Rate (2013-2018)
8 South America Imatinib Drug by Countries
8.1 South America Imatinib Drug Sales, Revenue and Market Share by Countries
8.1.1 South America Imatinib Drug Sales and Market Share by Countries (2013-2018)
8.1.2 South America Imatinib Drug Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Imatinib Drug Sales and Growth Rate (2013-2018)
8.3 Argentina Imatinib Drug Sales and Growth Rate (2013-2018)
8.4 Colombia Imatinib Drug Sales and Growth Rate (2013-2018)
9 Middle East and Africa Imatinib Drug by Countries
9.1 Middle East and Africa Imatinib Drug Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Imatinib Drug Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Imatinib Drug Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Imatinib Drug Sales and Growth Rate (2013-2018)
9.3 UAE Imatinib Drug Sales and Growth Rate (2013-2018)
9.4 Egypt Imatinib Drug Sales and Growth Rate (2013-2018)
9.5 Nigeria Imatinib Drug Sales and Growth Rate (2013-2018)
9.6 South Africa Imatinib Drug Sales and Growth Rate (2013-2018)
10 Global Imatinib Drug Market Segment by Type
10.1 Global Imatinib Drug Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Imatinib Drug Sales and Market Share by Type (2013-2018)
10.1.2 Global Imatinib Drug Revenue and Market Share by Type (2013-2018)
10.2 Tablets Sales Growth and Price
10.2.1 Global Tablets Sales Growth (2013-2018)
10.2.2 Global Tablets Price (2013-2018)
10.3 Capsules Sales Growth and Price
10.3.1 Global Capsules Sales Growth (2013-2018)
10.3.2 Global Capsules Price (2013-2018)
11 Global Imatinib Drug Market Segment by Application
11.1 Global Imatinib Drug Sales Market Share by Application (2013-2018)
11.2 Chronic myelogenous leukemia Sales Growth (2013-2018)
11.3 Gastrointestinal stromal tumors Sales Growth (2013-2018)
11.4 Others Sales Growth (2013-2018)
12 Imatinib Drug Market Forecast (2018-2023)
12.1 Global Imatinib Drug Sales, Revenue and Growth Rate (2018-2023)
12.2 Imatinib Drug Market Forecast by Regions (2018-2023)
12.2.1 North America Imatinib Drug Market Forecast (2018-2023)
12.2.2 Europe Imatinib Drug Market Forecast (2018-2023)
12.2.3 Asia-Pacific Imatinib Drug Market Forecast (2018-2023)
12.2.4 South America Imatinib Drug Market Forecast (2018-2023)
12.2.5 Middle East and Africa Imatinib Drug Market Forecast (2018-2023)
12.3 Imatinib Drug Market Forecast by Type (2018-2023)
12.3.1 Global Imatinib Drug Sales Forecast by Type (2018-2023)
12.3.2 Global Imatinib Drug Market Share Forecast by Type (2018-2023)
12.4 Imatinib Drug Market Forecast by Application (2018-2023)
12.4.1 Global Imatinib Drug Sales Forecast by Application (2018-2023)
12.4.2 Global Imatinib Drug Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Imatinib Drug Picture
Table Product Specifications of Imatinib Drug
Figure Global Sales Market Share of Imatinib Drug by Types in 2017
Table Imatinib Dr
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
